>> Monday
>> Friday
>> Saturday
>> Sunday
>> Monday
>> Tuesday
>> Wednesday
Monday 08 July 2024
08:30 - 09:30
Session 01: Keynote session
Monday 08 July 2024
08:30 - 09:30: Session 01: Keynote session:
Cornelis Lambalk, The Netherlands
08:30 - 09:00
Human Reproduction Keynote lecture: Progesterone for pregnant people with threatened miscarriage
09:00 - 09:30
CRISPR-Cas, from a bacterial defense system to a novel genetic tool in humans.
Raymond Staals, The Netherlands
09:30 - 10:30
Ziwig: Endometriosis 2.0 in the light of OMICS
09:30 - 10:30: Ziwig: Endometriosis 2.0 in the light of OMICS:
09:30 - 10:15
Towards a worldwide strategy to fight endometriosis
09:30 - 10:15
Is there a benefit of surgery for infertile patient with endometriosis?
Enda McVeigh, United Kingdom
09:30 - 10:15
Endometriosis and infertility: ARN as biomarkers for early diagnosis
Sofiane Bendifallah, France
10:15 - 10:30
Take home message
Caterina Exacoustos, Italy
09:30 - 10:00
Coffee break in the exhibit hall
09:30 - 10:00: Coffee break in the exhibit hall:
10:00 - 11:30
Session 02: The key players for success: the gametes
10:00 - 11:30: Session 02: The key players for success: the gametes:
Gemma Arroyo Cardona, Spain
Dorit Christina Kieslinger, The Netherlands
10:00 - 10:15
COC classifier: a new artificial intelligence-based tool for identifying mature oocytes from cumulus- oocyte-complexes.
Israel Maldonado Rosas, Mexico
10:15 - 10:30
Oocyte image assessment by novel artificial intelligence (AI) model predicts blastocyst PGT-A results, outperforming age as a predictor
10:30 - 10:45
The in vitro maturation rate of human oocytes is enhanced following uptake of extracellular vesicles derived from mature follicles
Sofia Makieva, Switzerland
10:45 - 11:00
Oocyte factors as predictors of abnormal, mononucleated and trinucleated, zygotes and assessment of their morphokinetic differences.
Jose Luis De Pablo Franco, Spain
11:00 - 11:15
Leveraging warning thresholds of oocyte immaturity rate to identify patients at risk of pathological endophenotypes. Analysis of 16,155 retrievals with implications for rescue-IVM.
11:15 - 11:30
Sperm-derived centrioles play a key role in ensuring correct chromosome segregation in the first mitotic division of mammalian zygotes
Ainhoa Larreategui, The Netherlands
10:00 - 11:30
Session 03: Smarter strategies to optimal ovarian stimulation - time to rethink (part 1)
10:00 - 11:30: Session 03: Smarter strategies to optimal ovarian stimulation - time to rethink (part 1):
Femke Mol, The Netherlands
10:00 - 10:15
Comparison of the flexible Progestin-Primed Ovarian Stimulation with the GnRH antagonist protocol in predicted suboptimal responders: a freeze-all randomized controlled trial
10:15 - 10:30
Luteal estradiol versus follicular GnRH antagonist for ovarian follicular synchronization in POSEIDON poor responders: A multicentric randomized controlled trial
10:30 - 10:45
Is there a need for LH surge inhibition by GnRH-antagonists in luteal phase stimulation in poor ovarian responders undergoing Duostim? Efficacy of natural progesterone.
10:45 - 11:00
Three Injections Protocol for IVF; a proof of concept study into elaborating the outmost patient friendly protocol in IVF
Evangelos Papanikolaou, Greece
11:00 - 11:15
Population pharmacokinetics of follitropin delta during ovarian stimulation
11:15 - 11:30
Cumulative live birth associated with number of oocytes in ovarian stimulation with follitropin delta: an individual patient data meta-analysis.
Ida Engberg Jepsen, Denmark
10:00 - 11:30
Session 04: How to improve sperm quality for ART?
10:00 - 11:30: Session 04: How to improve sperm quality for ART?:
Michael Carroll, United Kingdom
Liliana Ramos, The Netherlands
10:00 - 10:15
Enabling laboratory-quality male fertility analysis with 72-hour post-ejaculation sample viability
Ashwin Ramachandran, India
10:15 - 10:30
To be or not to be capacitated after sperm preparation: tyrosine phosphorylation as predictive indicator for capacitation status and male fertility potential
Ana Ortiz Vallecillo, Spain
10:30 - 10:45
Swim-up versus density gradients for sperm preparation in intrauterine insemination: a multi-centre randomised clinical trial
10:45 - 11:00
Utilisation of second successive ejaculate as a way to overcome poor semen parameters for couples who wish to undergo conventional-IVF
Panagiota Tsounapi, Japan
11:00 - 11:15
Outcomes and correlations between traditional Intracytoplasmic Sperm Injection (ICSI) method and a new AI-enhanced system
Dimitrios Mantas, United Arab Emirates
11:15 - 11:30
Investigating the effect of advanced sperm preparation techniques on embryo developmental potential and clinical outcomes: A network meta-analysis of Randomized Controlled Trials
10:00 - 11:30
Session 05: Imaging of endometriosis and endometrial disorders: roads to the future
10:00 - 11:30: Session 05: Imaging of endometriosis and endometrial disorders: roads to the future:
Edgardo Somigliana, Italy
Velja Mijatovic, The Netherlands
10:00 - 10:15
Magnetic Resonance Imaging (MRI) evaluation of Quinagolide Vaginal Ring (QVR) treatment on endometrioma, Deep Infiltrating Endometriosis (DIE), and adenomyosis lesion characteristics: QLARITY trial results
10:15 - 10:30
Early tubal flushing with oil-based contrast during hysterosalpingography versus no tubal flushing in women with unexplained infertility – H2Oil-timing randomized controlled trial
Danah Kamphuis, The Netherlands
10:30 - 10:45
Does flushing with oil-based contrast during hysterosalpingography (HSG) increase the live birth rate as compared to water-based contrast: A prospective cohort study
10:45 - 11:00
Age affects ultrasound markers of endometrial receptivity in artificial cycles
11:00 - 11:15
An artificial intelligence (AI) model non-invasively evaluates endometrial receptivity from ultrasound images, surpassing endometrial thickness (EMT) in predicting implantation
11:15 - 11:30
Development of deep learning-based model for differential diagnosis of ovarian neoplasm using pelvic ultrasonography
Yeon Hee Hong, Korea, South
10:00 - 11:30
Session 06: Therapeutic concepts in implantation and early pregnancy
10:00 - 11:30: Session 06: Therapeutic concepts in implantation and early pregnancy:
Lisa Lashley, The Netherlands
10:00 - 10:15
Efficacy results from the phase II randomized clinical trial: OXO-001 in infertile women undergoing egg donation IVF/ICSI
10:15 - 10:30
DNA methylation testing with cervical secretion can serve as a non-invasive biomarker for predicting successful implantation in frozen-thawed embryo transfer
Chii-Ruey Tzeng, Taiwan R.O.C.
10:30 - 10:45
Atosiban in women with previous single implantation failure undergoing frozen-thawed blastocyst transfer: A placebo-controlled randomized trial
10:45 - 11:00
The impact of aneuploidy on human peri-implantation development: findings from the extended in vitro culture of 191 human embryos
11:00 - 11:15
Tacrolimus treatment significantly improved IVF outcomes with euploid embryo transfer in women with repeated implantation failures (RIF) and elevated T helper (Th)1/Th2 cell ratios
11:15 - 11:30
Intravenous immunoglobulin and prednisolone to women with unexplained recurrent pregnancy loss undergoing assisted reproductive technology treatment: a randomized, double-blinded, placebo-controlled trial.
Caroline Nørgaard-Pedersen, Denmark
10:00 - 11:30
Session 07: Genetic frontiers: new insights in gamete and embryo research
10:00 - 11:30: Session 07: Genetic frontiers: new insights in gamete and embryo research:
Esther Baart, The Netherlands
10:00 - 10:15
Molecular insights into the decline in oocyte quality with advanced maternal age: findings from comprehensive single cell -omics analysis of 112 human oocytes
Styliani Galatidou, Ireland
10:15 - 10:30
Specific kir gene profiles and recurrent implantation failure
10:30 - 10:45
Euploidy's hidden potential: Emerging insights from abnormal fertilized embryos
Balsam Al Hashimi, United Kingdom
10:45 - 11:00
How much DNA is shared between a human egg and each of the polar bodies? Theory and genomic data from polar bodies and triploid embryos
11:00 - 11:15
An update on the genetics of dizygotic twinning
Dorret Boomsma, The Netherlands
11:15 - 11:30
Impact of maternal aging on the DNA repair landscape in mouse oocytes
10:00 - 11:30
Session 08: Poster discussion session - SQART
10:00 - 11:30: Session 08: Poster discussion session - SQART:
Aleksej Stevanovic, Norway
10:00 - 10:15
Congenital heart defects in children born after assisted reproductive technology: A large cohort study from the Committee of Nordic Assisted Reproductive Technology and Safety (CoNARTaS)
10:15 - 10:30
A decade of transformations in IVF strategies towards enhanced clinical efficacy, efficiency, and safety: the real-life experience of 6610 couples
10:30 - 10:45
Association between ovarian hyperstimulation syndrome and adverse obstetric and neonatal outcomes in Korea: a nationwide health insurance database study
Yunjeong Park, Korea, South
10:45 - 11:00
Exploration of maternal proteome over pregnancy based on corpus luteum number at conception
Frauke von Versen-Höynck, Germany
11:00 - 11:15
GLP-1 receptor agonist treatment in early pregnancy and risk of pregnancy complications - A nationwide cohort study
11:15 - 11:30
Twin births in Belgium: a national cohort analysis of 35 523 double fresh embryo transfers between 2012 and 2021
11:15 - 12:15
Theramex: Exploring the Role of dydrogesterone in Luteal Phase Support: Optimizing its use for Successful Implantation
11:15 - 12:15: Theramex: Exploring the Role of dydrogesterone in Luteal Phase Support: Optimizing its use for Successful Implantation:
11:15 - 11:25
Introduction
11:25 - 12:00
Is dydrogesterone the new standard of care in fresh cycle IVF?
Christophe Blockeel, Belgium
11:25 - 12:00
What is the fetal safety profile of dydrogesterone usage in ART?
Alexander Katalinic, Germany
11:25 - 12:00
How can dydrogesterone optimize FET cycle performance and outcomes?
Georg Griesinger, Germany
11:45 - 13:00
Ferring Pharmaceuticals:Follitropin Delta: A 10-year data driven journey
11:45 - 13:00: Ferring Pharmaceuticals:Follitropin Delta: A 10-year data driven journey:
A decade of transformation: Evolution in Reproductive Medicine
Ying C. Cheong, United Kingdom
11:55 - 12:10
Unraveling follitropin delta: Rigorous RCT programs for clinical development
Bart C.J.M. Fauser, The Netherlands
12:10 - 12:30
Exploring the depths: Insights from post-hoc analyses and meta-analyses in RCT repositories
Samuel Dos Santos-Ribeiro, Portugal
12:30 - 12:45
Translating to clinical practice: Validating trial findings in a real-world setting
Christophe Blockeel, Belgium
12:45 - 12:55
Future trajectories: Unveiling the path forward in follitropin delta research
12:55 - 13:00
Thank you and closing remarks
Ying C. Cheong, United Kingdom
11:45 - 12:45
Session 09: Debate: Late o’clock: are slow growing embryos clinically usable?
11:45 - 12:45: Session 09: Debate: Late o’clock: are slow growing embryos clinically usable?:
Ieva Masliukaite, The Netherlands
11:45 - 12:00
Con - the faster the better
12:00 - 12:15
Pro - better late than never
11:45 - 12:15
Session 10: Data reporting session
11:45 - 12:15: Session 10: Data reporting session:
Alwin Aha Derijck, The Netherlands
11:45 - 12:15
Data from the ESHRE PGT Consortium - year 2022
Francesca Spinella, Italy
11:45 - 12:45
Session 11: Debate: Dual and/or double trigger improve IVF success
11:45 - 12:45: Session 11: Debate: Dual and/or double trigger improve IVF success:
Nikolaos P. Polyzos, Spain
Joop Laven, The Netherlands
11:45 - 12:45
Session 12: ASRM Exchange session: Assisted reproductive technologies: new horizons
11:45 - 12:45: Session 12: ASRM Exchange session: Assisted reproductive technologies: new horizons:
Elizabeth Ginsburg, U.S.A.
11:45 - 12:00
The promise and peril of germline gene therapy
12:05 - 12:20
Does PGT improve outcomes in poor responders?
Elizabeth Ginsburg, U.S.A.
12:25 - 12:40
Fertility preservation in the male across the lifespan: A new paradigm
Robert E. Brannigan, U.S.A.
11:45 - 12:45
Session 13: Live Journal Club: Good practice recommendations on add-ons in reproductive medicine
11:45 - 12:45: Session 13: Live Journal Club: Good practice recommendations on add-ons in reproductive medicine:
Munevver Serdarogullari, Cyprus
Omar Ammar, United Kingdom
11:50 - 11:55
Paper presentation
Mina Mincheva, United Kingdom
11:55 - 12:00
Introduction of experts and moderators
Omar Ammar, United Kingdom
12:00 - 12:45
Main discussion
Ioannis Sfontouris, Greece
Nicholas Macklon, United Kingdom
Co-speaker[0000786160] Main discussion
Manuela Perrotta, United Kingdom
Cornelis Lambalk, The Netherlands
11:45 - 12:45
Session 14: Poster discussion session - Stem cells
11:45 - 12:45: Session 14: Poster discussion session - Stem cells:
11:45 - 12:00
Engineering Vascularized Human Endometrial Organoids for In Vivo Tissue Regeneration and Repair Applications
12:00 - 12:15
Heritable genome editing in haploid mouse embryonic stem cells
12:15 - 12:30
Trophoblast organoids as a 3D model for the study of oxygen concentration during in vitro preimplantation embryo culture
12:30 - 12:45
Assessment of embryo development following fertilization with de novo male gametes generated in a three-dimensional culture
13:00 - 14:00
Lunch break in the exhibit hall
13:00 - 14:00: Lunch break in the exhibit hall:
13:00 - 14:00
Thermo Fisher Scientific: Innovation and trends in reproductive health genetic testing
13:00 - 14:00: Thermo Fisher Scientific: Innovation and trends in reproductive health genetic testing:
13:00 - 13:03
Welcome note
13:03 - 13:15
Delivering premium PGT add-ons to go beyond classic PGT
13:15 - 13:27
Demystifying PGTA: invasive vs niPGTA
13:27 - 13:39
Coelocentesis and fetal health. Chromosome aneuploidies and monogenic disorders
Salvatore A. Longo, Italy
14:00 - 15:15
Gedeon Richter: Unveiling the Realms of Reproduction: A Comprehensive Dive into Modern Oocyte Assessment
14:00 - 15:15: Gedeon Richter: Unveiling the Realms of Reproduction: A Comprehensive Dive into Modern Oocyte Assessment:
David K. Gardner, Australia
Laura Francesca Rienzi, Italy
14:00 - 14:15
Exploring Lifestyle's patterns in Shaping Oocyte Destiny
Helen O'Neill, United Kingdom
14:15 - 14:30
Mapping Oocyte Morphology's Influence on Clinical Outcomes
14:30 - 14:40
Navigating the Contemporary Landscape of Oocyte Quality.
14:40 - 14:50
Decoding the Essential Indications in Oocyte Quality Assessment.
14:50 - 15:15
Panel discussion
14:00 - 15:00
Session 15: Endometriosis associated infertility
14:00 - 15:00: Session 15: Endometriosis associated infertility:
Christian Becker, United Kingdom
Annemiek Nap, The Netherlands
14:00 - 14:20
Understanding endometrial functionality and embryo-maternal communication via in vitro ‘’OMICs’’ platforms
Susana M. Chuva de Sousa Lopes, The Netherlands
14:30 - 14:50
Can we tailor ART to endometriosis patients?
Velja Mijatovic, The Netherlands
14:00 - 15:00
Session 16: New identified genetic causes of female infertility
14:00 - 15:00: Session 16: New identified genetic causes of female infertility:
Ron Van Golde, The Netherlands
14:00 - 14:20
Newly identified female mutations causing failed fertilization
Arantxa Cardona Barberán, Belgium
14:30 - 14:50
Newly identified female mutations causing oocyte maturation defect and embryo developmental arrest
14:00 - 15:00
Session 17: IFS/ISAR Exchange session: The ovary
14:00 - 15:00: Session 17: IFS/ISAR Exchange session: The ovary:
Sunita Tandulwadkar, India
14:00 - 14:12
ART in PCOS
Rishma Dhillon Pai, India
14:15 - 14:27
Ovarian rejuvenation - fact or fiction?
14:30 - 14:42
Ovarian cancer and fertility - current understanding
14:45 - 14:57
New strategies in ovarian stimulation
14:00 - 15:00
Session 18: Embryo "correction" mode to maximize success
14:00 - 15:00: Session 18: Embryo "correction" mode to maximize success:
Carlijn Vergouw, The Netherlands
14:00 - 14:15
How does the exclusion of blastomeres affect the outcome of euploid blastocysts?
Hakan Kadir Yelke, Turkey
14:15 - 14:30
Can artificial removal of the zona pellucida with severe fragmentation improve culture and pregnancy outcomes?
14:30 - 14:45
PGT-A reveals triploid embryos among normally fertilized oocytes: Frequency and blastocyst features.
14:45 - 15:00
Parental inheritance of monopronuclear blastocysts from ICSI cycles and its association with specific morphokinetic traits: a retrospective observational study
14:00 - 15:00
Session 19: International Reproductive Health Education Collaboration (IRHEC) – An update
14:00 - 15:00: Session 19: International Reproductive Health Education Collaboration (IRHEC) – An update:
Bola Grace, United Kingdom
14:00 - 14:20
An update from the international reproductive health education collaboration.
Joyce Harper, United Kingdom
14:30 - 14:50
Educating young people about reproductive health.
Rina Biswakarma, United Kingdom
14:00 - 15:00
Session 20: Poster discussion session - Fertility preservation
14:00 - 15:00: Session 20: Poster discussion session - Fertility preservation:
Claudia Massarotti, Italy
14:00 - 14:15
The age-associated increase in ovarian stiffness compromises follicle development and induces changes in the follicles’ transcriptome, resulting in poor-quality oocytes
14:15 - 14:30
Autologous cryopreserved ovarian tissue transplantation and perinatal outcomes: a systematic review with pooled analysis
14:30 - 14:45
Recombinant human anti-Müllerian hormone reduces doxorubicin-induced reproductive aging by regulating Id3 expression and promoting DNA repair
Eun Mi Chang, Korea, South
14:45 - 15:00
Fertility outcomes several years after fertility preservation for endometriosis
Rebecca Goldstein, France
14:45 - 15:45
CooperSurgical: Up Close and Personal with Alviggi and Campbell - Treatment Options: Evidence and Insights for Clinic and Lab
14:45 - 15:45: CooperSurgical: Up Close and Personal with Alviggi and Campbell - Treatment Options: Evidence and Insights for Clinic and Lab:
Alison Campbell, United Kingdom
15:15 - 16:30
Session 21: Intersecting pathways: genetics, proteins, and embryology
15:15 - 16:30: Session 21: Intersecting pathways: genetics, proteins, and embryology:
Giovanni Coticchio, Italy
Edith Coonen, The Netherlands
15:15 - 15:30
The first mitotic spindle instability impacts nucleation, fragmentation, and development in human embryos
15:30 - 15:45
Cas9-based chromosome labelling reveals large-scale age-dependent centromere reorganisation in human oocytes
Aleksandra Byrska, United Kingdom
15:45 - 16:00
Stringent statistical analysis of 108,684 oocyte donation cycles identifies 2.6% of donors with specific oocyte/embryo developmental arrest phenotypes for genome association studies.
Christian Simon Ottolini, United Kingdom
16:00 - 16:15
The canonical Hippo signalling pathway controls the first lineage segregation in the human preimplantation embryo
Panagiotis Stamatiadis, Belgium
16:15 - 16:30
CD163 in follicular fluids can be the novel marker to predict clinical outcome of oocyte.
15:15 - 16:30
Session 22: It all starts with the egg - updates and new advances
15:15 - 16:30: Session 22: It all starts with the egg - updates and new advances:
Tom Adriaenssens, Belgium
Madelon Van Wely, The Netherlands
15:15 - 15:30
Dual trigger is not superior to GnRH Agonist alone for final oocyte maturation in elective fertility preservation. A Randomized Controlled Trial.
15:30 - 15:45
Particulate matter (PM2.5 and PM10) exposure prior to oocyte collection is associated with decreased live birth rates in subsequent frozen embryo transfers
Sebastian Leathersich, Australia
15:45 - 16:00
Novel method to enhance preantral follicle growth by granulocyte colony-stimulating factor administration improves embryos and pregnancy rate in poor ovarian reserve: a randomized controlled trial
16:00 - 16:15
Depletion of MFF from oocytes impairs mitochondrial dynamics, leading to inhibited oocyte maturation and early embryonic development in mice
16:15 - 16:30
Deletion of interlukin-17A protects against ovarian aging via activating wnt10b/β-catenin signaling
15:15 - 16:30
Session 23: Novel insights on psychosocial outcomes
15:15 - 16:30: Session 23: Novel insights on psychosocial outcomes:
Mariana Sousa Leite, United Kingdom
15:15 - 15:30
Reflecting on the fertility journey: Insights from couples who discontinued fertility treatment without giving birth
Laurie Beauvilliers, Canada
15:30 - 15:45
The effect of psychosocial support on motivation for assisted reproductive treatments
Judit Szigeti F., Hungary
15:45 - 16:00
Navigating the crossroads: Unraveling predictors for treatment discontinuation in couples pursuing assisted reproduction: Findings from a 2-year prospective study
Katherine Péloquin, Canada
16:00 - 16:15
From words to wellness: a retrospective study leveraging large language models on conversational data to uncover patient needs
16:15 - 16:30
Sexual function in women with Premature Ovarian Insufficiency (POI): systematic review and meta-analysis
Charissa van Zwol - Janssens, The Netherlands
15:15 - 16:30
Session 24: Female fertility preservation - focus on outcomes
15:15 - 16:30: Session 24: Female fertility preservation - focus on outcomes:
Mariette Goddijn, The Netherlands
15:15 - 15:30
Outcomes of female fertility preservation with cryopreservation of oocytes or embryos: a population-based study
Elena ter Welle - Butalid, The Netherlands
15:30 - 15:45
Oocyte cryopreservation: a comprehensive analysis of live birth rate by age and indication of treatment provides reassurance for young cancer patients.
Michal Kirshenbaum, Australia
15:45 - 16:00
Risk of serious adverse event after fertility preservation procedures: a comparison of cancer and non-cancer patients
16:00 - 16:15
Use and safety of assisted reproductive technology in young BRCA carriers with a pregnancy after treatment for breast cancer: results from an international cohort study
Isotta Martha Magaton, Switzerland
16:15 - 16:30
Effect of low, medium and high risk chemotherapy on the ovarian reserve in children: results of the interim analysis of a prospective multicentric trial (CHANCE)
Isabelle Demeestere, Belgium
15:15 - 16:30
Session 25: The alpha and omega of safety and quality in ART
15:15 - 16:30: Session 25: The alpha and omega of safety and quality in ART:
Charine van Tilborg, The Netherlands
15:15 - 15:30
Association of pituitary suppression method with euploid blastocyst yield in preimplantation genetic testing for aneuploidy (PGT-A) cycles
15:30 - 15:45
The paradox of choice in double (DET) versus single (SET) embryo transfer: more is less!
Jan-Steffen Krüssel, Germany
15:45 - 16:00
Severe maternal and neonatal morbidity among gestational carriers: a population-based cohort study
16:00 - 16:15
Prevalence of multiple gestation births and perinatal outcomes in pregnancies secondary to clomiphene citrate treatment: a nationwide cohort study
16:15 - 16:30
Infant mortality after assisted reproductive technology – a Nordic collaborative study on 7,947,575 liveborn children
15:15 - 16:30
Session 26: Advances and challenges in modeling human reproduction
15:15 - 16:30: Session 26: Advances and challenges in modeling human reproduction:
Susana M. Chuva de Sousa Lopes, The Netherlands
15:15 - 15:30
Novel stem cell-based twin embryo model reveals inner cell mass division and enhanced endometrial adhesion in monochorionic twin development.
Erik Vrij, The Netherlands
15:30 - 15:45
Assessment of genome editing outcomes in human preimplantation embryos subjected to CRISPR-Cas9 – most loss of heterozygosity (LOH) events are caused by DNA repair deficiency
Nada Kubikova, United Kingdom
15:45 - 16:00
Human fallopian tube organoids provide a favorable environment for sperm motility
16:00 - 16:15
Implantation-on-chip: precise quantification for functional implantation failure studies
16:15 - 16:30
The transcriptome of endometrial organoids of fertile and subfertile women exposed to seminal plasma of fertile men
Jonna van den Berg, The Netherlands
15:15 - 16:30
Session 27: Poster discussion session - Implantation and early pregnancy
15:15 - 16:30: Session 27: Poster discussion session - Implantation and early pregnancy:
15:15 - 15:30
Monozygotic twins from in vitro fertilization: can bring the rate closer to that of natural conception?
15:30 - 15:45
Comparison of luteal support protocols in fresh IVF/ICSI cycles: A network meta-analysis.
Stavroula Lila Kastora, United Kingdom
15:45 - 16:00
Non-autologous human platelet lysate as a therapy for recurrent implantation failure: lessons from in vitro models
Tina Tu-Thu Ngoc Nguyen, Canada
16:00 - 16:15
Lower ectopic pregnancy prevalence with natural endometrial preparation in single euploid frozen embryo transfers
Raquel Del Gallego, United Arab Emirates
16:15 - 16:30
Perinatal outcomes after recurrent pregnancy loss: a systematic review and meta-analysis
Isabelle Letourneau, Canada
16:30 - 17:00
Coffee break in the exhibit hall
16:30 - 17:00: Coffee break in the exhibit hall:
17:00 - 18:15
IBSA: Adenomyosis in ART: uncharted territory
17:00 - 18:15: IBSA: Adenomyosis in ART: uncharted territory:
Dominique De Ziegler, France
17:00 - 17:05
Welcome and introduction
17:05 - 17:25
Diagnosing of adenomyosis: ultrasound, MUSA criteria and MRI
Caterina Exacoustos, Italy
17:25 - 17:45
Adenomyosis in the clinic: symptomatic or asymptomatic
17:45 - 18:05
Adenomyosis in ART
Juan A. Garcia-Velasco, Spain
18:05 - 18:15
Take home messages
Dominique De Ziegler, France
17:00 - 18:00
Session 28: Implantation update from research and practice
17:00 - 18:00: Session 28: Implantation update from research and practice:
Antonis Makrigiannakis, Greece
Merel van den Berg, The Netherlands
17:00 - 17:20
Implantation 2024 - What do we know?
Siobhan Quenby, United Kingdom
17:30 - 17:50
Chronic endometritis - Research and practice
17:00 - 18:00
Session 29: DNA damage in gametes: origin, repair and clinical relevance
17:00 - 18:00: Session 29: DNA damage in gametes: origin, repair and clinical relevance:
Frank J. Broekmans, The Netherlands
17:00 - 17:20
From spermatozoa to embryos
17:30 - 17:50
From oocytes to embryos
17:00 - 18:00
Session 30: Family size in ART
17:00 - 18:00: Session 30: Family size in ART:
Yvonne Louwers, The Netherlands
The challenge of European populations: between low and late fertility, aging and growing migration flow
Gianpiero Dalla Zuanna, Italy
17:30 - 17:50
Contribution of ART to fertility rates and family size
Georgina Chambers, Australia
17:00 - 18:00
Session 31: Fertility awareness from childhood to adulthood
17:00 - 18:00: Session 31: Fertility awareness from childhood to adulthood:
Valerie Blanchet De Mouzon, France
Sarah Michon, The Netherlands
17:00 - 17:15
The FERTILITAS study: exploring parenthood intentions among reproductive-aged individuals without children in Belgium
Eva Van Steijvoort, Belgium
17:15 - 17:30
The contribution of women's modes of conception, self-mastery, perceived stress, and cognitive appraisal to personal growth in two phases during pregnancy
Elad Mijalevich-Soker, Israel
17:30 - 17:45
Acceptance rates and reasons for social oocyte cryopreservation among women: systematic review and meta-analysis
İlkay Güngör Satılmış, Turkey
17:45 - 18:00
Reproductive health education: collaborative design of a learning platform for secondary school education involving reproductive health experts, pupils, and teachers
17:00 - 18:30
Session 32: Guidelines session: ESHRE Guidelines for clinicians
17:00 - 18:30: Session 32: Guidelines session: ESHRE Guidelines for clinicians:
Richard Anderson, United Kingdom
Annemieke Hoek, The Netherlands
17:00 - 17:20
Premature ovarian insufficiency: new data and updated guidance
Nick Panay, United Kingdom
17:30 - 17:50
ESGO / ESHRE / ESGE Guidelines for the fertility sparing treatment & follow-up in gynecological cancers
17:00 - 18:00
Session 33: Poster discussion session - Psychology & counselling
17:00 - 18:00: Session 33: Poster discussion session - Psychology & counselling:
Mariana Moura-Ramos, Portugal
17:00 - 17:15
The experiences and outcomes of donor conceived adults in the UK who are actively searching, open to contact with, and not searching for donor connections
Sophie Zadeh, United Kingdom
17:15 - 17:30
Multicentre two-arm randomised controlled trial of Beyond Fertility: A brief face-to-face psychosocial intervention to promote patients’ healthy adjustment when ending unsuccessful fertility treatment
Mariana Sousa Leite, United Kingdom
17:30 - 17:45
Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome
Tamara Jannink, The Netherlands
17:45 - 18:00
Infertility stigma, openness with others, and their relationship to depression and meaning in life among men and women experiencing infertility
08:00 - 18:00
IFFS Committee meeting
08:00 - 18:00: IFFS Committee meeting:
09:00 - 10:00
ESHRE 2025 - LOC
09:00 - 10:00: ESHRE 2025 - LOC:
09:00 - 11:00
PGT Steering Comittee meeting
09:00 - 11:00: PGT Steering Comittee meeting:
10:00 - 12:00
OS update guideline meeting
10:00 - 12:00: OS update guideline meeting:
09:30 - 17:00
Fertility Europe meeting
09:30 - 17:00: Fertility Europe meeting:
11:00 - 12:00
ESHRE-ALMER meeting
11:00 - 12:00: ESHRE-ALMER meeting:
12:00 - 14:00
Human Reproduction Associate Editors' meeting
12:00 - 14:00: Human Reproduction Associate Editors' meeting:
12:00 - 14:00
Molecular Human Reproduction Associate Editors' meeting
12:00 - 14:00: Molecular Human Reproduction Associate Editors' meeting:
12:00 - 14:00
ICMART Contributors meeting
12:00 - 14:00: ICMART Contributors meeting:
12:00 - 14:00
EMCC Committee meeting Part 2
12:00 - 14:00: EMCC Committee meeting Part 2:
12:00 - 14:00
Good practice recommendation on Expanded Carrier Screening meeting
12:00 - 14:00: Good practice recommendation on Expanded Carrier Screening meeting:
12:30 - 14:00
Ethics in PGT - writing group
12:30 - 14:00: Ethics in PGT - writing group:
13:00 - 14:00
ESHRE Committee of National Representatives meeting
13:00 - 14:00: ESHRE Committee of National Representatives meeting:
13:00 - 15:00
PGT Consortium General Assembly meeting
13:00 - 15:00: PGT Consortium General Assembly meeting:
14:00 - 15:30
ATCRM meeting
14:00 - 15:30: ATCRM meeting:
14:00 - 16:30
NMCC Committee meeting Part 1
14:00 - 16:30: NMCC Committee meeting Part 1:
14:30 - 16:30
FP in boys and adolescent males guideline meeting
14:30 - 16:30: FP in boys and adolescent males guideline meeting:
15:00 - 16:00
ESHRE-IFS/ISAR meeting
15:00 - 16:00: ESHRE-IFS/ISAR meeting:
15:00 - 17:00
Focus group between "Stem Cells" and "Ethics and Law" meeting
15:00 - 17:00: Focus group between "Stem Cells" and "Ethics and Law" meeting:
15:30 - 17:00
EIM Steering Committee meeting
15:30 - 17:00: EIM Steering Committee meeting:
16:15 - 17:00
CSAO/FSANZ Award Committee meeting
16:15 - 17:00: CSAO/FSANZ Award Committee meeting: